Plain-English translation of NCT06482190 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This early-stage trial is testing a new medication called RSN0402 that you would inhale as a powder. Researchers want to understand how safe the medication is, how well your body tolerates it, and how your body processes it. The study involves healthy volunteers receiving either the medication or a placebo (inactive treatment).
Lung fibrosis is a serious condition where lung tissue becomes scarred and stiff, making it harder to breathe. This medication is being developed as a potential treatment, but before it can be tested in patients with the disease, researchers need to make sure it is safe when given to healthy people first.
You likely qualify if…
You likely don't qualify if…
The study has two main parts. In the first part, you would visit the clinic and inhale a single dose of either the medication or placebo, then be monitored to see how your body responds. In the second part, you would receive doses over 7 days and return for check-ups. Throughout the study, you'll have blood tests, lung function tests, and heart monitoring to make sure everything is going well. The entire study lasts several weeks, and you'll need to fast for 10 hours before certain visits.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Australia